Market Tracker

05/23 5:16pm ET

Redhill Biopharma Ltd (NASDAQ:RDHL)

10.11
Delayed Data
As of 3:59pm ET
 -0.20 / -1.94%
Today’s Change
8.78
Today|||52-Week Range
16.54
-3.35%
Year-to-Date
No recent news for Redhill Biopharma Ltd.

Today’s Trading

Previous close10.31
Today’s open10.12
Day’s range10.01 - 10.23
Volume63,016
Average volume (3 months)58,297
Market cap$169.9M
Dividend yield--
Data as of 3:59pm ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)-21.48%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+3,278.54%
P/E ratio--
Price/Sales1,329.82
Price/Book2.61

Competitors

 Today’s
change
Today’s
% change
CURRCure Pharmaceutical ...-0.05-0.66%
PPHMPeregrine Pharmaceut...-0.00-0.57%
FOMXFoamix Pharmaceutica...+0.12+2.73%
IMDZImmune Design Corp-0.25-3.27%
Data as of 3:59pm ET, 05/23/2017

Financials

Next reporting dateJuly 26, 2017
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$101.3K
Annual profit (last year)-$29.5M
Net profit margin-29,079.21%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Chief Operating Officer
Gilead Raday
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts